Canadian Melanoma Conference

2014 Canadian Melanoma Conference
Mark Your Calendars!

February 20 to 23, 2014
Rimrock Resort Hotel, Banff, Alberta

 

2014 Conference Date Announcement

The 2014 Canadian Melanoma Conference will take place at the Rimrock Resort Hotel Februray 20 to 23, 2014. Mark your calendars!

Overview


The Canadian Melanoma Conference is Canada's flagship meeting on the research and treatment of melanoma. It brings together Medical Oncologists, Surgeons, Dermatologists, Radiotherapists, Pathologists, Molecular Biologists, and Immunologists to review the latest evidence and explore new therapies.

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada, and approved by the Division of Continuous Professional Learning, University of Alberta

2013 Learning Objectives

  • Communicate state-of-the-art knowledge in biology, pathogenesis, and melanoma pathology
  • Review the biological basis of bRAF inhibition and the clinical implications in the management of melanoma
  • Present pre-clinical and clinical research regarding Braf inhibition in melanoma
  • Provide an update on the use of anti-CTLA4 therapy, including the evaluation of response and the management of immune-related toxicities
  • Review the specific challenges of acral melamonas
  • Share novel research strategies and initiatives being conducted across Canada
  • Identify new targets and targeted agents in the treatment of melanoma such as PD-1
  • Identify key industry partners who would prioritize the development of products and programs in melanoma management in Canada
  • Continue to build the network of basic and clinical investigators in order to promote translational and clinical research across Canada
  • Discuss short- and long-term research strategies

Program Planning Committee

Chair: Michael Smylie, Medical Oncologist, Department of Medical Oncology, Cross Cancer Institute; Professor, University of Alberta

Joel Claveau, Melanoma and Pigmented Lesions Clinic, Hôpital Hôtel-Dieu de Québec

Scott Ernst, Head, Division of Medical Oncology, London Regional Cancer Program

David Hogg, Professor of Medicine, Departments of Medicine and Medical Biophysics, University of Toronto

Greg McKinnon, Professor of Surgery and Oncology, University of Calgary and Tom Baker Cancer Centre

Teresa Petrella, Medical Oncologist, Sunnybrook Odette Cancer Centre

Thomas Salopek, Director of Dermatology, Associate Professor, University of Alberta

Alan Spatz, Professor of Pathology and Oncology, Department of Pathology, McGill University

 

Canadian Melanoma Conference
c/o BUKSA Strategic Conference Services
Suite 307, 10328 - 81 Avenue NW, Edmonton, AB T6E 1X2
Phone: 780.436.0983 ext. 227 Fax: 780.437.5984 Email:melanoma@buksa.com